Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: DRUG ADMINISTRATION SCHEDULE - , . Treffer: 170

2021

McCarthy, O; Deere, R; Churm, R; Dunseath, GJ; Jones, C; Eckstein, ML; Williams, DM; Hayes, J; Pitt, J; Bain, SC; Moser, O; Bracken, RM Extent and prevalence of post-exercise and nocturnal hypoglycemia following peri-exercise bolus insulin adjustments in individuals with type 1 diabetes.
NUTR METAB CARDIOVAS. 2021; 31(1): 227-236. Doi: 10.1016/j.numecd.2020.07.043 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Eggermont, AMM; Rutkowski, P; Dutriaux, C; Hofman-Wellenhof, R; Dziewulski, P; Marples, M; Grange, F; Lok, C; Pennachioli, E; Robert, C; van Akkooi, ACJ; Bastholt, L; Minisini, A; Marshall, E; Salès, F; Grob, JJ; Bechter, O; Schadendorf, D; Marreaud, S; Kicinski, M; Suciu, S; Testori, AAE Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial.
Eur J Cancer. 2020; 133(8):94-103 Doi: 10.1016/j.ejca.2020.04.015
Web of Science PubMed FullText FullText_MUG

 

2019

Amrein, K; Parekh, D; Westphal, S; Preiser, JC; Berghold, A; Riedl, R; Eller, P; Schellongowski, P; Thickett, D; Meybohm, P; VITDALIZE Collaboration Group Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study).
BMJ Open. 2019; 9(11):e031083-e031083 Doi: 10.1136/bmjopen-2019-031083 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Freynhofer, MK; Hein-Rothweiler, R; Haller, PM; Aradi, D; Dézsi, DA; Gross, L; Orban, M; Trenk, D; Geisler, T; Huczek, Z; Toth-Gayor, GG; Massberg, S; Huber, K; Sibbing, D Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study.
Thromb Haemost. 2019; 119(4):660-667 Doi: 10.1055/s-0038-1677549
Web of Science PubMed FullText FullText_MUG

 

Lechleitner, M; Clodi, M; Abrahamian, H; Brath, H; Brix, J; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Harreiter, J; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Kautzky-Willer, A; Ludvik, B; Luger, A; Mader, JK; Paulweber, B; Pieber, T; Prager, R; Rami-Merhar, B; Resl, M; Riedl, M; Roden, M; Saely, CH; Schelkshorn, C; Schernthaner, G; Sourij, H; Stechemesser, L; Stingl, H; Toplak, H; Wascher, TC; Weitgasser, R; Winhofer-Stöckl, Y; Zlamal-Fortunat, S [Insulin therapy of type 2 diabetes mellitus (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):39-46 Doi: 10.1007/s00508-019-1492-7
Web of Science PubMed FullText FullText_MUG

 

Skrabl-Baumgartner, A; Seidel, G; Langner-Wegscheider, B; Schlagenhauf, A; Jahnel, J Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis.
Arch Dis Child. 2019; 104(3):246-250 Doi: 10.1136/archdischild-2018-315060
Web of Science PubMed FullText FullText_MUG

 

Tomaniak, M; Chichareon, P; Onuma, Y; Deliargyris, EN; Takahashi, K; Kogame, N; Modolo, R; Chang, CC; Rademaker-Havinga, T; Storey, RF; Dangas, GD; Bhatt, DL; Angiolillo, DJ; Hamm, C; Valgimigli, M; Windecker, S; Steg, PG; Vranckx, P; Serruys, PW; GLOBAL LEADERS Trial Investigators Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.
JAMA Cardiol. 2019; 4(11):1092-1101 Doi: 10.1001/jamacardio.2019.3355 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Winter, MP; von Lewinski, D; Wallner, M; Prüller, F; Kolesnik, E; Hengstenberg, C; Siller-Matula, JM Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study.
Sci Rep. 2019; 9(1):8194-8194 Doi: 10.1038/s41598-019-44673-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Aygören-Pürsün, E; Bygum, A; Grivcheva-Panovska, V; Magerl, M; Graff, J; Steiner, UC; Fain, O; Huissoon, A; Kinaciyan, T; Farkas, H; Lleonart, R; Longhurst, HJ; Rae, W; Triggiani, M; Aberer, W; Cancian, M; Zanichelli, A; Smith, WB; Baeza, ML; Du-Thanh, A; Gompels, M; Gonzalez-Quevedo, T; Greve, J; Guilarte, M; Katelaris, C; Dobo, S; Cornpropst, M; Clemons, D; Fang, L; Collis, P; Sheridan, W; Maurer, M; Cicardi, M Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
NEW ENGL J MED. 2018; 379(4): 352-362. Doi: 10.1056/NEJMoa1716995 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dempster, DW; Brown, JP; Fahrleitner-Pammer, A; Kendler, D; Rizzo, S; Valter, I; Wagman, RB; Yin, X; Yue, SV; Boivin, G Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.
J Clin Endocrinol Metab. 2018; 103(7):2498-2509 Doi: 10.1210/jc.2017-02669 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Indolfi, G; Hierro, L; Dezsofi, A; Jahnel, J; Debray, D; Hadzic, N; Czubkowski, P; Gupte, G; Mozer-Glassberg, Y; van der Woerd, W; Smets, F; Verkade, HJ; Fischler, B Treatment of Chronic Hepatitis C Virus Infection in Children: A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
J Pediatr Gastroenterol Nutr. 2018; 66(3):505-515 Doi: 10.1097/MPG.0000000000001872
Web of Science PubMed FullText FullText_MUG

 

Leonardi, C; Maari, C; Philipp, S; Goldblum, O; Zhang, L; Burkhardt, N; Ball, S; Mallbris, L; Gonzalez, P; Fernández-Peñas, P; Puig, L Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study.
J Am Acad Dermatol. 2018; 79(5):824-830 Doi: 10.1016/j.jaad.2018.05.032
Web of Science PubMed FullText FullText_MUG

 

Mahla, E; Metzler, H; Bornemann-Cimenti, H; Prueller, F; Raggam, RB; Pregartner, G; Berghold, A; Baumann, A; Goeroeg, C; Gurbel, PA Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
Thromb Haemost. 2018; 118(5):864-872 Doi: 10.1055/s-0038-1641153
Web of Science PubMed FullText FullText_MUG

 

Mahla, E; Tantry, US; Prüller, F; Gurbel, PA Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
Circulation. 2018; 138(19):2145-2159 Doi: 10.1161/CIRCULATIONAHA.118.035160
Web of Science PubMed FullText FullText_MUG

 

2017

Brozek, W; Reichardt, B; Zwerina, J; Dimai, HP; Klaushofer, K; Zwettler, E Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.
Osteoporos Int. 2017; 28(5):1587-1595 Doi: 10.1007/s00198-017-3910-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fahrleitner-Pammer, A; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Toffis, C; Frieling, I; Geusens, P; Makras, P; Boschitsch, E; Callens, J; Anastasilakis, AD; Niedhart, C; Resch, H; Kalouche-Khalil, L; Hadji, P Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.
Arch Osteoporos. 2017; 12(1):58-58 Doi: 10.1007/s11657-017-0351-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fung, P; Bedogni, G; Bedogni, A; Petrie, A; Porter, S; Campisi, G; Bagan, J; Fusco, V; Saia, G; Acham, S; Musto, P; Petrucci, MT; Diz, P; Colella, G; Mignogna, MD; Pentenero, M; Arduino, P; Lodi, G; Maiorana, C; Manfredi, M; Hallberg, P; Wadelius, M; Takaoka, K; Leung, YY; Bonacina, R; Schiødt, M; Lakatos, P; Taylor, T; De Riu, G; Favini, G; Rogers, SN; Pirmohamed, M; Nicoletti, P; GENVABO Consortium; Fedele, S Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
Oral Dis. 2017; 23(4):477-483 Doi: 10.1111/odi.12632 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Holman, RR; Bethel, MA; Mentz, RJ; Thompson, VP; Lokhnygina, Y; Buse, JB; Chan, JC; Choi, J; Gustavson, SM; Iqbal, N; Maggioni, AP; Marso, SP; Öhman, P; Pagidipati, NJ; Poulter, N; Ramachandran, A; Zinman, B; Hernandez, AF; EXSCEL Study Group Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2017; 377(13): 1228-1239. Doi: 10.1056/NEJMoa1612917 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mueller, RB; Graninger, W; Sidiropoulos, P; Goger, C; von Kempis, J Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysis of the Swiss and Austrian patients from the ACT-SURE study.
Clin Rheumatol. 2017; 36(10):2187-2192 Doi: 10.1007/s10067-017-3779-2
Web of Science PubMed FullText FullText_MUG

 

Palkovits, S; Seidel, G; Pertl, L; Malle, EM; Hausberger, S; Makk, J; Singer, C; Osterholt, J; Herzog, SA; Haas, A; Weger, M MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Retina. 2017; 37(12):2262-2268 Doi: 10.1097/IAE.0000000000001480
Web of Science PubMed FullText FullText_MUG

 

Pölzl, G; Altenberger, J; Baholli, L; Beltrán, P; Borbély, A; Comin-Colet, J; Delgado, JF; Fedele, F; Fontana, A; Fruhwald, F; Giamouzis, G; Giannakoulas, G; Garcia-González, MJ; Gustafsson, F; Kaikkonen, K; Kivikko, M; Kubica, J; von Lewinski, D; Löfman, I; Malfatto, G; Manito, N; Martínez-Sellés, M; Masip, J; Merkely, B; Morandi, F; Mølgaard, H; Oliva, F; Pantev, E; Papp, Z; Perna, GP; Pfister, R; Piazza, V; Bover, R; Rangel-Sousa, D; Recio-Mayoral, A; Reinecke, A; Rieth, A; Sarapohja, T; Schmidt, G; Seidel, M; Störk, S; Vrtovec, B; Wikström, G; Yerly, P; Pollesello, P Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
Int J Cardiol. 2017; 243(3):389-395 Doi: 10.1016/j.ijcard.2017.05.081 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sezer, O; Beksac, M; Hajek, R; Sucak, G; Cagirgan, S; Linkesch, W; Meltem Akay, O; Gülbas, Z; Nahi, H; Plesner, T; Snowden, JA; Timurağaoğlu, A; Dechow, T; Lang, A; Tuğlular, T; Drach, J; Armbrecht, G; Potamianou, A; Couturier, C; Olie, RA; Feys, C; Allietta, N; Terpos, E Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol. 2017; 178(1):61-71 Doi: 10.1111/bjh.14637 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sticherling, M; Franke, A; Aberer, E; Gläser, R; Hertl, M; Pfeiffer, C; Rzany, B; Schneider, S; Shimanovich, I; Werfel, T; Wilczek, A; Zillikens, D; Schmidt, E An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
Br J Dermatol. 2017; 177(5):1299-1305 Doi: 10.1111/bjd.15649
Web of Science PubMed FullText FullText_MUG

 

2016

Abrahamian, H; Kautzky-Willer, A; Rießland-Seifert, A; Fasching, P; Ebenbichler, C; Hofmann, P; Toplak, H [Mental disorders and diabetes mellitus].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S170-S178 Doi: 10.1007/s00508-015-0939-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Bethel, MA; Harrison, P; Sourij, H; Sun, Y; Tucker, L; Kennedy, I; White, S; Hill, L; Oulhaj, A; Coleman, RL; Holman, RR Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
Diabet Med. 2016; 33(2):224-230 Doi: 10.1111/dme.12828
Web of Science PubMed FullText FullText_MUG

 

Blevins, T; Pieber, TR; Colón Vega, G; Zhang, S; Bastyr, EJ; Chang, AM; IMAGINE 4 Investigators Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4.
Diabetes Obes Metab. 2016; 18(11):1072-1080 Doi: 10.1111/dom.12696 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Bohn, B; Karges, B; Vogel, C; Otto, KP; Marg, W; Hofer, SE; Fröhlich-Reiterer, E; Holder, M; Plamper, M; Wabitsch, M; Kerner, W; Holl, RW; DPV Initiative 20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes.
PLoS One. 2016; 11(8):e0160971-e0160971 Doi: 10.1371/journal.pone.0160971 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Buttgereit, F; Dejaco, C; Matteson, EL; Dasgupta, B Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
JAMA. 2016; 315(22):2442-2458 Doi: 10.1001/jama.2016.5444
Web of Science PubMed FullText FullText_MUG

 

Clodi, M; Abrahamian, H; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Hoppichler, F; Kaser, S; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Prager, R; Fröhlich-Reiterer, E; Roden, M; Säly, C; Schernthaner, G; Sourij, H; Toplak, H; Wascher, TC; Weitgasser, R [Antihyperglycemic treatment guidelines for diabetes mellitus type 2].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S45-S53 Doi: 10.1007/s00508-016-0991-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fabian, E; Bordag, N; Herold, M; Kamp, H; Krennrich, G; Looser, R; Ma-Hock, L; Mellert, W; Montoya, G; Peter, E; Prokudin, A; Spitzer, M; Strauss, V; Walk, T; Zbranek, R; van Ravenzwaay, B Metabolite profiles of rats in repeated dose toxicological studies after oral and inhalative exposure.
Toxicol Lett. 2016; 255: 11-23. Doi: 10.1016/j.toxlet.2016.05.003
Web of Science PubMed FullText FullText_MUG

 

Goldinger, SM; Gobbi Bischof, S; Fink-Puches, R; Klemke, CD; Dréno, B; Bagot, M; Dummer, R Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.
JAMA Dermatol. 2016; 152(7):837-839 Doi: 10.1001/jamadermatol.2016.0401 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Heise, T; Korsatko, S; Nosek, L; Coester, HV; Deller, S; Roepstorff, C; Segel, S; Kapur, R; Haahr, H; Hompesch, M Steady state is reached within 2-3 days of once-daily administration of degludec, a basal insulin with an ultralong duration of action.
J Diabetes. 2016; 8(1):132-138 Doi: 10.1111/1753-0407.12266
Web of Science PubMed FullText FullText_MUG

 

Holman, RR; Bethel, MA; George, J; Sourij, H; Doran, Z; Keenan, J; Khurmi, NS; Mentz, RJ; Oulhaj, A; Buse, JB; Chan, JC; Iqbal, N; Kundu, S; Maggioni, AP; Marso, SP; Öhman, P; Pencina, MJ; Poulter, N; Porter, LE; Ramachandran, A; Zinman, B; Hernandez, AF Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.
Am Heart J. 2016; 174(6):103-110 Doi: 10.1016/j.ahj.2015.12.009 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Klamroth, R; Simpson, M; von Depka-Prondzinski, M; Gill, JC; Morfini, M; Powell, JS; Santagostino, E; Davis, J; Huth-Kühne, A; Leissinger, C; Neumeister, P; Bensen-Kennedy, D; Feussner, A; Limsakun, T; Zhou, M; Veldman, A; St Ledger, K; Blackman, N; Pabinger, I Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A.
Haemophilia. 2016; 22(5):730-738 Doi: 10.1111/hae.12985 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moinzadeh, P; Riemekasten, G; Siegert, E; Fierlbeck, G; Henes, J; Blank, N; Melchers, I; Mueller-Ladner, U; Frerix, M; Kreuter, A; Tigges, C; Lahner, N; Susok, L; Guenther, C; Zeidler, G; Pfeiffer, C; Worm, M; Karrer, S; Aberer, E; Bretterklieber, A; Genth, E; Simon, JC; Distler, JH; Hein, R; Schneider, M; Seitz, CS; Herink, C; Steinbrink, K; Sárdy, M; Varga, R; Mensing, H; Mensing, C; Lehmann, P; Neeck, G; Fiehn, C; Weber, M; Goebeler, M; Burkhardt, H; Buslau, M; Ahmadi-Simab, K; Himsel, A; Juche, A; Koetter, I; Kuhn, A; Sticherling, M; Hellmich, M; Kuhr, K; Krieg, T; Ehrchen, J; Sunderkoetter, C; Hunzelmann, N; German Network for Systemic Scleroderma Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients.
J Rheumatol. 2016; 43(1):66-74 Doi: 10.3899/jrheum.150382 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Novacek, G; Dejaco, C; Gröchenig, HP; Högenauer, C; Knoflach, P; Miehsler, W; Moschen, A; Petritsch, W; Vogelsang, H; Tilg, H [In Process Citation].
Z Gastroenterol. 2016; 54(5):456-467 Doi: 10.1055/s-0042-103694
Web of Science PubMed FullText FullText_MUG

 

Radda, S; Bolz, M; Egger, S; Gasser-Steiner, V; Kralinger, M; Mennel, S; Scholda, C; Stolba, U; Wedrich, A; Krepler, K [Diagnosis, treatment and monitoring of diabetic eye control].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S97-102 Doi: 10.1007/s00508-016-0983-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE Diabetes in the youth].
Wien Klin Wochenschr. 2016; 128 Suppl 2(3):S119-S123 Doi: 10.1007/s00508-015-0922-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rodbard, HW; Cariou, B; Pieber, TR; Endahl, LA; Zacho, J; Cooper, JG Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial.
Diabetes Obes Metab. 2016; 18(3):274-280 Doi: 10.1111/dom.12609 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schernthaner, G; Drexel, H; Rosenkranz, A; Schernthaner, GH; Watschinger, B Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016].
Wien Klin Wochenschr. 2016; 128 Suppl 2(21):S62-S67 Doi: 10.1007/s00508-015-0924-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stadler, M; Zlamal-Fortunat, S; Schütz-Fuhrmann, I; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, S; Mader, J; Resl, M; Kautzky-Willer, A; Weitgasser, R; Prager, R; Bischof, M [Insulin pump therapy in children, adolescents and adults].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S188-S195 Doi: 10.1007/s00508-016-0966-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Toplak, H; Hoppichler, F; Wascher, TC; Schindler, K; Ludvik, B [Obesity and type 2 diabetes].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S196-S200 Doi: 10.1007/s00508-016-0986-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wascher, TC; Paulweber, B; Toplak, H; Säly, CH; Drexel, H; Föger, B; Hoppichler, F [Lipids--Diagnosis and therapy in diabetes mellitus].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S68-S70 Doi: 10.1007/s00508-015-0933-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weiss, TW; Aichinger, J; Huber, K; Speidl, WS; Watzinger, N; Zweiker, R; Alber, HF Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction.
Wien Klin Wochenschr. 2016; 128(11-12):450-457 Doi: 10.1007/s00508-016-1016-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Dejaco, C; Singh, YP; Perel, P; Hutchings, A; Camellino, D; Mackie, S; Abril, A; Bachta, A; Balint, P; Barraclough, K; Bianconi, L; Buttgereit, F; Carsons, S; Ching, D; Cid, M; Cimmino, M; Diamantopoulos, A; Docken, W; Duftner, C; Fashanu, B; Gilbert, K; Hildreth, P; Hollywood, J; Jayne, D; Lima, M; Maharaj, A; Mallen, C; Martinez-Taboada, V; Maz, M; Merry, S; Miller, J; Mori, S; Neill, L; Nordborg, E; Nott, J; Padbury, H; Pease, C; Salvarani, C; Schirmer, M; Schmidt, W; Spiera, R; Tronnier, D; Wagner, A; Whitlock, M; Matteson, EL; Dasgupta, B; European League Against Rheumatism; American College of Rheumatology 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
Ann Rheum Dis. 2015; 74(10):1799-1807 Doi: 10.1136/annrheumdis-2015-207492 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dejaco, C; Singh, YP; Perel, P; Hutchings, A; Camellino, D; Mackie, S; Matteson, EL; Dasgupta, B Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.
Ann Rheum Dis. 2015; 74(10):1808-1817 Doi: 10.1136/annrheumdis-2015-207578 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hadji, P; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Zhang, E; Frieling, I; Geusens, P; Makras, P; Resch, H; Möller, G; Kalouche-Khalil, L; Fahrleitner-Pammer, A Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
Osteoporos Int. 2015; 26(10):2479-2489 Doi: 10.1007/s00198-015-3164-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hilbe, W; Pall, G; Kocher, F; Pircher, A; Zabernigg, A; Schmid, T; Schumacher, M; Jamnig, H; Fiegl, M; Gächter, A; Freund, M; Kendler, D; Manzl, C; Zelger, B; Popper, H; Wöll, E Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).
PLoS One. 2015; 10(5):e0125364-e0125364 Doi: 10.1371/journal.pone.0125364 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Longhurst, HJ; Aberer, W; Bouillet, L; Caballero, T; Fabien, V; Zanichelli, A; Maurer, M; IOS Investigators Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey.
Allergy Asthma Proc. 2015; 36(5):399-406 Doi: 10.2500/aap.2015.36.3892
Web of Science PubMed FullText FullText_MUG

 

Marovt, M; El Shabrawi-Caelen, L Purpuric bullous pemphigoid.
Am J Dermatopathol. 2015; 37(2):e18-e20 Doi: 10.1097/DAD.0000000000000057 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum